. 2024 Aug 7;16(16):2784. doi: 10.3390/cancers16162784
© 2024 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Figure 2.
Treatment patterns of TP53m AML and CR rates.